ACR适当性标准®恶性或侵袭性原发性肌肉骨骼肿瘤的分期与监测:2022年更新
该指南由美国放射学会(ACR)制定,基于证据和专家意见,针对恶性或侵袭性原发性肌肉骨骼肿瘤的分期与监测,按五个临床场景给出影像检查推荐。指南强调胸部影像是分期和监测的核心,因为此类肿瘤最常见的转移部位是肺;原发肿瘤切除后一般推荐对原发部位进行监测,骨起源与软组织起源的局部监测影像推荐不同。
要点
- 恶性或侵袭性原发性肌肉骨骼肿瘤罕见,胸部影像是分期和监测的核心,因最常见转移部位为肺。
- 原发肿瘤切除后一般推荐对原发部位进行监测,骨起源与软组织起源的局部监测推荐不同。
- 指南按五个临床场景整合当前证据与专家意见,给出影像分期与监测推荐。
核心结论
- 胸部影像在恶性或侵袭性原发性肌肉骨骼肿瘤的分期和监测中不可或缺,因肺是最常见转移部位。
- 原发肿瘤切除后一般推荐对原发部位进行监测,局部监测影像推荐因骨起源与软组织起源而异。
- 指南将当前证据与专家意见整合为五个临床场景,用于此类肿瘤的影像分期与监测。
研究设计与样本
- 制定机构:美国放射学会(ACR);方法:基于证据的适当性标准指南,由多学科专家小组每年审查。
- 指南制定与修订过程支持对同行评审期刊文献的系统分析,采用GRADE等既定方法学原则评价证据。
- 采用RAND/UCLA适当性方法用户手册确定特定临床场景下影像和治疗程序的适当性。
- 当同行评审文献缺乏或模棱两可时,专家可能是制定推荐的主要证据来源。
临床应用与阅片要点
- 胸部影像用于恶性或侵袭性原发性肌肉骨骼肿瘤的分期和监测,因肺为最常见转移部位。
- 原发肿瘤切除后一般推荐对原发部位进行监测,骨起源与软组织起源的局部监测影像推荐不同。
- 指南按五个临床场景给出影像分期与监测推荐,具体推荐条款及推荐等级见原文全文。
局限性
- 当同行评审文献缺乏或模棱两可时,专家可能是制定推荐的主要证据来源。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Malignant or aggressive primary musculoskeletal tumors are rare and encompass a wide variety of bone and soft tissue tumors. Given the most common site for metastasis from these primary musculoskeletal tumors is to the lung, chest imaging is integral in both staging and surveillance. Extrapulmonary metastases are rarely encountered with only a few exceptions. Following primary tumor resection, surveillance of the primary tumor site is generally recommended. Local surveillance imaging recommendations differ between primary tumors of bone origin versus soft tissue origin. This document consolidates the current evidence and expert opinion for the imaging staging and surveillance of these tumors into five clinical scenarios. The ACR Appropriateness Criteria are evidence-based guidelines for specific clinical conditions that are reviewed annually by a multidisciplinary expert panel. The guideline development and revision process support the systematic analysis of the medical literature from peer-reviewed journals. Established methodology principles such as Grading of Recommendations Assessment, Development, and Evaluation or GRADE are adapted to evaluate the evidence. The RAND/UCLA Appropriateness Method User Manual provides the methodology to determine the appropriateness of imaging and treatment procedures for specific clinical scenarios. In those instances in which peer-reviewed literature is lacking or equivocal, experts may be the primary evidentiary source available to formulate a recommendation.
引用
- Stanborough R, Demertzis JL, Wessell DE, et al. ACR Appropriateness Criteria® Malignant or Aggressive Primary Musculoskeletal Tumor-Staging and Surveillance: 2022 Update. J Am Coll Radiol. 2022. PMID: 36436964. doi:10.1016/j.jacr.2022.09.015
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。